We enrolled 9 patients who were diagnosed with AAGN by renal biopsy and 9 patients who underwent tumor nephrectomies without diabetes or chronic renal disease to assess the expression levels of EZH2 and H3K27me3 via immunohistochemistry (IHC) staining. This evidence concerns the gene EZH2 and neoplasm.